Comparative Study on Streptokinase, Reteplase and Tenecteplase in the management of ST-Elevated Myocardial Infarction
G Nikitha, K Chowdary, KN Vani… - Research Journal of …, 2020 - indianjournals.com
Aims The aim of this study was to compare the effectiveness and adverse reactions of the
three thrombolytic agents viz. Streptokinase, Reteplase and Tenecteplase in the …
three thrombolytic agents viz. Streptokinase, Reteplase and Tenecteplase in the …
A Study on the Assessment of Risk in the Management of Acute Coronary Syndrome using GRACE score
N Chandra, S Govula, B Swathi, P Soumya - Journal of Clinical and …, 2023 - jcpr.in
Aim: To assess the risk in the management of acute coronary syndrome by using GRACE
score. Methods: This was an observational study conducted among 155 patients of …
score. Methods: This was an observational study conducted among 155 patients of …
[PDF][PDF] Investigating the relationship between serum pentraxin3 level and angiographic findings in patients with coronary angiography
H Heybar, A Assareh, S Jalali - Asian J Pharm Clin Res, 2018 - academia.edu
ABSTRACT Objective: Pentraxin3 (PTX3) is an inflammatory single-phase mononuclear
polysorbate glycoprotein, synthesized by endothelial, macrophages, and mildew cells; …
polysorbate glycoprotein, synthesized by endothelial, macrophages, and mildew cells; …
[PDF][PDF] Effectiveness and comparison of reteplase versus streptokinase thrombolytic agents in the patients of acute myocardial infarction
SK Goel, I Goel, S Agarwal - Int. J. Med. Sci. Public Health, 2017 - academia.edu
Background: Streptokinase and reteplase are commonly used for thrombolytic therapy in the
patients with acute myocardial infarction (AMI). A comparative study was designed to …
patients with acute myocardial infarction (AMI). A comparative study was designed to …